RecruitingNCT06295263

Application of AI Technology for the Diagnosis and Treatment of Geriatric Diseases

Sponsor

Qilu Hospital of Shandong University

Enrollment

460 participants

Start Date

Mar 1, 2022

Study Type

OBSERVATIONAL

Conditions

Alzheimer Disease Parkinson Disease Nervous System Diseases Geriatric Diseases

Summary

1\) Characteristics of handwriting, gait, speech, eye movements, biological samples (blood, urine, stool, saliva, etc.), images, EEG, and other relevant markers in patients with Alzheimer's disease. (2) Characteristics of handwriting, gait, language, eye movement, biological samples (blood, urine, stool, saliva, etc.), imaging, EEG, and other relevant markers in patients with Parkinson's disease. (3) Characteristics of handwriting, gait, language, eye movement, biological samples (blood, urine, stool, saliva, etc.), images, EEG, and other relevant markers in patients with other neurological disorders. (4) Characteristics of handwriting, gait, language, eye movement, biological samples (blood, urine, stool, saliva, etc.), images, EEG and other relevant markers in elderly patients.

Eligibility

Min Age: 8 YearsMax Age: 100 Years

Plain Language Summary

Simplified for easier understanding

This study is investigating how artificial intelligence (AI) tools can improve the diagnosis and care of elderly patients with Parkinson's disease, Alzheimer's disease, and other neurodegenerative conditions. Researchers are enrolling patients with these conditions along with healthy older adults to develop and test AI-assisted diagnostic approaches. **You may be eligible if...** - You have been diagnosed with primary Parkinson's disease (meeting 2015 MDS diagnostic criteria) - You have been diagnosed with Alzheimer's disease (meeting IWG-2 criteria) - You have another neurodegenerative disease (non-PD, non-AD) - You are a healthy elderly adult willing to serve as a comparison participant **You may NOT be eligible if...** - You have severe mental illness that prevents cooperation with testing - Your cognitive impairment is severe (MMSE score below 24) in certain study groups - You do not meet the specific diagnostic criteria for the enrolled group Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERHandwriting, gait, speech, eye movements, biological samples (blood, urine, stool, saliva, etc.), images, EEG, and other relevant markers

Handwriting, gait, speech, eye movements, biological samples (blood, urine, stool, saliva, etc.), images, EEG, and other relevant markers in all experimental and control groups